Top compounds associated with response to RABL2A


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.0097 0.8
mRNA Mdivi-1 CTRPv2 pan-cancer AAC 0.0093 0.8
mRNA PLX4720 CTRPv2 pan-cancer AAC 0.0089 0.8
mRNA bid1870 gCSI pan-cancer AAC 0.014 0.8
mRNA FSC231 CTRPv2 pan-cancer AAC -0.019 0.8
mRNA YK 4-279 GDSC1000 pan-cancer AAC -0.0091 0.8
mRNA BRD-K09344309 CTRPv2 pan-cancer AAC -0.021 0.8
mRNA AZD1480 CTRPv2 pan-cancer AAC 0.013 0.8
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0092 0.8
mRNA gossypol CTRPv2 pan-cancer AAC 0.0089 0.8
Download CSV